Os-pep (5 μg/g, i.p., on alternating days for 45 days) remarkably increased pre- and postsynaptic protein levels in AD (AβO-treated, APP/PS1) and Adipo−/− mice (Fig. 5a-c). Here, APP is linked to Alzheimer disease.